Ajax loader

Types 

Types 

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: VASELLA-Daniel

NOVARTIS/
RTR3E4E1 
February 22, 2013 
Swiss drugmaker Novartis CEO Joe Jimenez (L) and Ulrich Lehner, member of the Board of Directors attend... 
Basel, Switzerland 
Swiss drugmaker Novartis CEO Jimenez and Lehner, member of the Board of Directors attend the the annual... 
Swiss drugmaker Novartis CEO Joe Jimenez (L) and Ulrich Lehner, member of the Board of Directors attend the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E4DY 
February 22, 2013 
Ulrich Lehner, member of the Board of Directors of Swiss drug maker Novartis addresses the the annual... 
Basel, Switzerland 
Lehner, member of the Board of Directors of Swiss drug maker Novartis addresses the the annual shareholders... 
Ulrich Lehner, member of the Board of Directors of Swiss drug maker Novartis addresses the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E4DW 
February 22, 2013 
Designated successor Joerg Reinhardt is seen on a huge TV screen as outgoing Chairman of Swiss drug maker... 
Basel, Switzerland 
Designated successor Reinhardt is seen on a huge TV screen as outgoing utgoing Chairman of Swiss drug... 
Designated successor Joerg Reinhardt is seen on a huge TV screen as outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E4DT 
February 22, 2013 
Designated successor Joerg Reinhardt is seen on a huge TV screen as outgoing Chairman of Swiss drug maker... 
Basel, Switzerland 
Designated successor Reinhardt is seen on a huge TV screen as outgoing utgoing Chairman of Swiss drug... 
Designated successor Joerg Reinhardt is seen on a huge TV screen as outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E4DQ 
February 22, 2013 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the the annual shareholders... 
Basel, Switzerland 
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the the annual shareholders general... 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. On front left sits Ulrich Lehner, Member of the Board of Directors. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E4DP 
February 22, 2013 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella (C) explains a device for voting during... 
Basel, Switzerland 
Outgoing Chairman of Swiss drug maker Novartis Vasella explains a device for voting during the the annual... 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella (C) explains a device for voting during the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E4DM 
February 22, 2013 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the the annual shareholders... 
Basel, Switzerland 
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the the annual shareholders general... 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. On front left sits Ulrich Lehner, Member of the Board of Directors. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E43U 
February 22, 2013 
Dominique Biedermann, Executive director of Ethos Swiss Foundation for Sustainable Development, asks... 
Basel, Switzerland 
Biedermann Executive director of Ethos asks questions during the annual shareholders general meeting... 
Dominique Biedermann, Executive director of Ethos Swiss Foundation for Sustainable Development, asks questions to outgoing Chairman of Swiss drug maker Novartis Daniel Vasella during the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E43S 
February 22, 2013 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella pauses during the annual shareholders general... 
Basel, Switzerland 
Outgoing Chairman of Swiss drug maker Novartis Vasella pauses during the annual shareholders general... 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella pauses during the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E43Q 
February 22, 2013 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general... 
Basel, Switzerland 
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting... 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E422 
February 22, 2013 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general... 
Basel, Switzerland 
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting... 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E41R 
February 22, 2013 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general... 
Basel, Switzerland 
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting... 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann (SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E41Q 
February 22, 2013 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general... 
Basel, Switzerland 
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting... 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E41N 
February 22, 2013 
Swiss drugmaker Novartis CEO Joe Jimenez (L) delivers his speech next to outgoing Chairman Daniel Vasella... 
Basel, Switzerland 
Swiss drugmaker Novartis CEO Jimenez delivers his speech next to outgoing Chairman Vasella during the... 
Swiss drugmaker Novartis CEO Joe Jimenez (L) delivers his speech next to outgoing Chairman Daniel Vasella (C) during the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann (SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E41M 
February 22, 2013 
Swiss drugmaker Novartis CEO Joe Jimenez (L) delivers his speech next to outgoing Chairman Daniel Vasella... 
Basel, Switzerland 
Swiss drugmaker Novartis CEO Jimenez delivers his speech next to outgoing Chairman Vasella during the... 
Swiss drugmaker Novartis CEO Joe Jimenez (L) delivers his speech next to outgoing Chairman Daniel Vasella during the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann (SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E41J 
February 22, 2013 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general... 
Basel, Switzerland 
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting... 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann (SWITZERLAND - Tags: BUSINESS HEALTH TPX IMAGES OF THE DAY) 
NOVARTIS/
RTR3E41I 
February 22, 2013 
Swiss drugmaker Novartis CEO Joe Jimenez (L) arrives for his speech next to outgoing Chairman Daniel... 
Basel, Switzerland 
Swiss drugmaker Novartis CEO Jimenez arrives for his speech next to outgoing Chairman Vasella during... 
Swiss drugmaker Novartis CEO Joe Jimenez (L) arrives for his speech next to outgoing Chairman Daniel Vasella during the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann (SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E40J 
February 22, 2013 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella (R) arrives with Ulrich Lehner, Member... 
Basel, Switzerland 
Outgoing Chairman of Swiss drug maker Novartis Vasella arrives with Lehner Member of the Board of Directors... 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella (R) arrives with Ulrich Lehner, Member of the Board of Directors, for the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E40I 
February 22, 2013 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general... 
Basel, Switzerland 
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting... 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E40F 
February 22, 2013 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general... 
Basel, Switzerland 
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting... 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E40E 
February 22, 2013 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella arrives at the annual shareholders general... 
Basel, Switzerland 
Outgoing Chairman of Swiss drug maker Novartis Vasella arrives at the annual shareholders general meeting... 
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella arrives at the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E40D 
February 22, 2013 
A member of the Youth faction of the Socialist Party (Juso) wearing a mask with Daniel Vasella portrait... 
Basel, Switzerland 
A member of the Juso wearing a mask with Vasella portrait throws fake banknotes during a demonstration... 
A member of the Youth faction of the Socialist Party (Juso) wearing a mask with Daniel Vasella portrait throws fake banknotes during a demonstration before Swiss drug maker Novartis annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH CIVIL UNREST) 
NOVARTIS/
RTR3E40C 
February 22, 2013 
A member of the Youth faction of the Socialist Party (Juso) wearing a mask with Daniel Vasella portrait... 
Basel, Switzerland 
A member of the Juso wearing a mask with Vasella portrait throws fake banknotes during a demonstration... 
A member of the Youth faction of the Socialist Party (Juso) wearing a mask with Daniel Vasella portrait throws fake banknotes during a demonstration before Swiss drug maker Novartis annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH CIVIL UNREST) 
NOVARTIS/
RTR3E406 
February 22, 2013 
A logo is pictured on a building of Swiss drug maker Novartis before its annual general meeting in Pratteln... 
Basel, Switzerland 
A logo is pictured on a building of Swiss drug maker Novartis before its annual general meeting in Pratteln... 
A logo is pictured on a building of Swiss drug maker Novartis before its annual general meeting in Pratteln near Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
NOVARTIS/
RTR3E3ZT 
February 22, 2013 
Shareholders queue to enter the St.Jakob Halle for Swiss drug maker Novartis annual general meeting in... 
Basel, Switzerland 
Shareholders queue to enter the St.Jakob Halle for Swiss drug maker Novartis annual general meeting in... 
Shareholders queue to enter the St.Jakob Halle for Swiss drug maker Novartis annual general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH) 
DAVOS/
RTR3DZQM 
February 19, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT) 
DAVOS/
RTR3DZQL 
February 19, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT) 
DAVOS/
RTR3DZQK 
February 19, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT) 
DAVOS/
RTR3DZQH 
February 19, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT) 
DAVOS/
RTR3DZQF 
February 19, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT) 
DAVOS/
RTR3DZQE 
February 19, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT) 
DAVOS/
RTR3DZQC 
February 19, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT) 
NOVARTIS-VASELLA/
RTR3DZ7F 
February 19, 2013 
Daniel Vasella, chairman of Swiss drugmaker Novartis, drinks coffee before the annual news conference... 
Basel, Switzerland 
File photo of Vasella, chairman of Swiss drugmaker Novartis, drinking coffee before the annual news conference... 
Daniel Vasella, chairman of Swiss drugmaker Novartis, drinks coffee before the annual news conference in Basel, January 23, 2013. Novartis said on February 19, 2013 it would scrap a 72 million Swiss franc ($77.98 million) pay package for outgoing chairman Vasella, bowing to mounting anger in Switzerland before an investor meeting on February 22. Picture taken January 23, 2013. REUTERS/Michael Buholzer (SWITZERLAND - Tags: BUSINESS HEALTH) 
DAVOS
RTR3CY04 
January 25, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Vasella Chairman of Novartis attends annual meeting of WEF in Davos 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH)
DAVOS
RTR3CY00 
January 25, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Vasella Chairman of Novartis attends annual meeting of WEF in Davos 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH HEADSHOT)
DAVOS
RTR3CXZZ 
January 25, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Vasella Chairman of Novartis attends annual meeting of WEF in Davos 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH)
DAVOS
RTR3CXZY 
January 25, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Vasella Chairman of Novartis attends annual meeting of WEF in Davos 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH)
DAVOS
RTR3CXZW 
January 25, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Vasella Chairman of Novartis attends annual meeting of WEF in Davos 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH HEADSHOT)
DAVOS
RTR3CXZV 
January 25, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Vasella Chairman of Novartis attends annual meeting of WEF in Davos 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH HEADSHOT)
DAVOS
RTR3CXZU 
January 25, 2013 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos... 
Davos, Switzerland 
Vasella Chairman of Novartis attends annual meeting of WEF in Davos 
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH HEADSHOT)
DAVOS
RTR3CXZQ 
January 25, 2013 
Daniel Vasella Chairman of Novartis steps over a chair on to the stage as he arrives to address delegates... 
Davos, Switzerland 
Vasella Chairman of Novartis arrives to address delegates during annual meeting of WEF in Davos 
Daniel Vasella Chairman of Novartis steps over a chair on to the stage as he arrives to address delegates during the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH)
NOVARTIS/
RTR3CTXG 
January 23, 2013 
Daniel Vasella, chairman of Swiss drugmaker Novartis, stirs a cup of coffee as he speaks to a journalist... 
Basel, Switzerland 
Daniel Vasella, chairman of Swiss drugmaker Novartis, stirs a cup of coffee before an annual news conference... 
Daniel Vasella, chairman of Swiss drugmaker Novartis, stirs a cup of coffee as he speaks to a journalist before an annual news conference in Basel January 23, 2013. Vasella, a former chief executive who has served as Novartis as chairman for 17 years, said January 23, 2013 he would not stand for re-election to the board of directors. REUTERS/Michael Buholzer (SWITZERLAND - Tags: BUSINESS) 
NOVARTIS/
RTR3CTXC 
January 23, 2013 
Daniel Vasella, chairman of Swiss drugmaker Novartis, speaks to a journalist before the annual news conference... 
Basel, Switzerland 
Vasella, chairman of Swiss drugmaker Novartis, speaks to a journalist before the annual news conference... 
Daniel Vasella, chairman of Swiss drugmaker Novartis, speaks to a journalist before the annual news conference in Basel January 23, 2013. Vasella, a former chief executive who has served as Novartis as chairman for 17 years, said January 23, 2013 he would not stand for re-election to the board of directors. REUTERS/Michael Buholzer (SWITZERLAND - Tags: BUSINESS) 
NOVARTIS/
RTR3CTX9 
January 23, 2013 
Daniel Vasella, chairman of Swiss drugmaker Novartis, stirs a cup of coffee as he speaks to a journalist... 
Basel, Switzerland 
Daniel Vasella, chairman of Swiss drugmaker Novartis, stirs a cup of coffee before an annual news conference... 
Daniel Vasella, chairman of Swiss drugmaker Novartis, stirs a cup of coffee as he speaks to a journalist before an annual news conference in Basel January 23, 2013. Vasella, a former chief executive who has served as Novartis as chairman for 17 years, said January 23, 2013 he would not stand for re-election to the board of directors. REUTERS/Michael Buholzer (SWITZERLAND - Tags: BUSINESS) 
NOVARTIS/
RTR3CTX7 
January 23, 2013 
Daniel Vasella, chairman of Swiss drugmaker Novartis, speaks to a journalist before the annual news conference... 
Basel, Switzerland 
Vasella, chairman of Swiss drugmaker Novartis, speaks to a journalist before the annual news conference... 
Daniel Vasella, chairman of Swiss drugmaker Novartis, speaks to a journalist before the annual news conference in Basel January 23, 2013. Vasella, a former chief executive who has served as Novartis as chairman for 17 years, said January 23, 2013 he would not stand for re-election to the board of directors. REUTERS/Michael Buholzer (SWITZERLAND - Tags: BUSINESS) 
NOVARTIS/PROTESTS
RTR2TD9K 
October 29, 2011 
Youth faction of the Socialist Party (Juso) members demonstrate in front of Novartis Chairman of the... 
RISCH, Switzerland 
Juso members demonstrate in front of Novartis Chairman of the Board Vasella's villa during "occupy villa... 
Youth faction of the Socialist Party (Juso) members demonstrate in front of Novartis Chairman of the Board Daniel Vasella's villa during "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the villa of Novartis AG Chairman Vasella on Saturday in protest at hefty job cuts planned by the Swiss pharmaceutical company. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday. REUTERS/Christian Hartmann (SWITZERLAND - Tags: HEALTH BUSINESS EMPLOYMENT CIVIL UNREST) 
NOVARTIS/PROTESTS
RTR2TD9H 
October 29, 2011 
Youth faction of the Socialist Party (Juso) members demonstrate in front of Novartis Chairman of the... 
RISCH, Switzerland 
Juso members demonstrate in front of Novartis Chairman of the Board Vasella's villa during "occupy villa... 
Youth faction of the Socialist Party (Juso) members demonstrate in front of Novartis Chairman of the Board Daniel Vasella's villa during "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the villa of Novartis AG Chairman Vasella on Saturday in protest at hefty job cuts planned by the Swiss pharmaceutical company. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday. REUTERS/Christian Hartmann (SWITZERLAND - Tags: HEALTH BUSINESS EMPLOYMENT CIVIL UNREST) 
NOVARTIS/PROTESTS
RTR2TD9F 
October 29, 2011 
Youth faction of the Socialist Party (Juso) members demonstrate in front of Novartis Chairman of the... 
RISCH, Switzerland 
Juso members demonstrate in front of Novartis Chairman of the Board Vasella's villa during "occupy villa... 
Youth faction of the Socialist Party (Juso) members demonstrate in front of Novartis Chairman of the Board Daniel Vasella's villa during "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the villa of Novartis AG Chairman Vasella on Saturday in protest at hefty job cuts planned by the Swiss pharmaceutical company. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday. REUTERS/Christian Hartmann (SWITZERLAND - Tags: HEALTH BUSINESS EMPLOYMENT CIVIL UNREST) 
NOVARTIS/PROTESTS
RTR2TD9D 
October 29, 2011 
Novartis Chairman of the Board Daniel Vasella gets a placard as he talks with youth faction of the Socialist... 
RISCH, Switzerland 
Novartis Chairman of the Board Vasella talks with Juso protesters during "occupy villa Vasella" protest... 
Novartis Chairman of the Board Daniel Vasella gets a placard as he talks with youth faction of the Socialist Party (Juso) protesters during "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the villa of Novartis AG Chairman Vasella on Saturday in protest at hefty job cuts planned by the Swiss pharmaceutical company. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday. REUTERS/Christian Hartmann (SWITZERLAND - Tags: HEALTH BUSINESS EMPLOYMENT CIVIL UNREST) 
NOVARTIS/PROTESTS
RTR2TD9B 
October 29, 2011 
A cameraman films as police officers secure the access to the villa of Novartis Chairman of the Board... 
RISCH, Switzerland 
A cameraman films as police officers secure the access to the villa of Novartis Chairman of the Board... 
A cameraman films as police officers secure the access to the villa of Novartis Chairman of the Board Daniel Vasella during a youth faction of the Socialist Party (Juso) "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the villa of Novartis AG Chairman Vasella on Saturday in protest at hefty job cuts planned by the Swiss pharmaceutical company. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday. REUTERS/Christian Hartmann (SWITZERLAND - Tags: HEALTH BUSINESS EMPLOYMENT CIVIL UNREST) 
NOVARTIS/PROTESTS
RTR2TD99 
October 29, 2011 
Novartis Chairman of the Board Daniel Vasella talks with youth faction of the Socialist Party (Juso)... 
RISCH, Switzerland 
Novartis Chairman of the Board Vasella talks Juso protesters during "occupy villa Vasella" protest action... 
Novartis Chairman of the Board Daniel Vasella talks with youth faction of the Socialist Party (Juso) protesters during "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the villa of Novartis AG Chairman Vasella on Saturday in protest at hefty job cuts planned by the Swiss pharmaceutical company. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday. REUTERS/Christian Hartmann (SWITZERLAND - Tags: HEALTH BUSINESS EMPLOYMENT CIVIL UNREST) 
DAVOS/
RTXX878 
January 29, 2011 
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum (WEF) in... 
Davos, Switzerland 
Novartis Chairman of the Board Vasella attends a session at the World Economic Forum in Davos 
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum (WEF) in Davos January 29, 2011. Organisers and CEOs at the annual Davos meeting projected cautious confidence in the global economy as the event opened on Wednesday, pointing to numerous risks which could yet derail a still-fragile recovery. REUTERS/Christian Hartmann (SWITZERLAND - Tags: POLITICS BUSINESS) 
DAVOS/
RTXX873 
January 29, 2011 
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum (WEF) in... 
Davos, Switzerland 
Novartis Chairman of the Board Vasella attends a session at the World Economic Forum in Davos 
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum (WEF) in Davos January 29, 2011. Organisers and CEOs at the annual Davos meeting projected cautious confidence in the global economy as the event opened on Wednesday, pointing to numerous risks which could yet derail a still-fragile recovery. REUTERS/Christian Hartmann (SWITZERLAND - Tags: POLITICS BUSINESS) 
DAVOS/
RTXX860 
January 29, 2011 
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum (WEF) in... 
Davos, Switzerland 
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum in Davos 
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum (WEF) in Davos January 29, 2011. Organisers and CEOs at the annual Davos meeting projected cautious confidence in the global economy as the event opened on Wednesday, pointing to numerous risks which could yet derail a still-fragile recovery. REUTERS/Christian Hartmann (SWITZERLAND - Tags: POLITICS BUSINESS) 
SWITZERLAND/
RTR2AXW6 
February 26, 2010 
Daniel Vasella, Chairman and former Chief Executive Officer (CEO) of Swiss drugmaker Novartis gives an... 
Basel, Switzerland 
Daniel Vasella, Chairman and former Chief Executive Officer of Swiss drugmaker Novartis gives an address... 
Daniel Vasella, Chairman and former Chief Executive Officer (CEO) of Swiss drugmaker Novartis gives an address at the annual general meeting in Basel February 26, 2010. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS SOCIETY) 
SWITZERLAND/
RTR2AXW0 
February 26, 2010 
Daniel Vasella (R), Chairman and former Chief Executive Officer (CEO) of Swiss drugmaker Novartis reacts... 
Basel, Switzerland 
Novartis Chairman Vasella reacts next to new CEO Jimenez as they attend their annual general meeting... 
Daniel Vasella (R), Chairman and former Chief Executive Officer (CEO) of Swiss drugmaker Novartis reacts as he stands next to new CEO Joe Jimenez during his address at the annual general meeting in Basel February 26, 2010. Jimenez started in his new position on February 1, 2010. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS SOCIETY) 
SWITZERLAND/
RTR2AXS6 
February 26, 2010 
Daniel Vasella, Chairman and former Chief Executive Officer of Swiss drugmaker Novartis gives an address... 
Basel, Switzerland 
Daniel Vasella, Chairman and former Chief Executive Officer of Swiss drugmaker Novartis gives an address... 
Daniel Vasella, Chairman and former Chief Executive Officer of Swiss drugmaker Novartis gives an address at the annual general meeting in Basel February 26, 2010. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS HEALTH) 
SWITZERLAND/
RTR2AXRW 
February 26, 2010 
Daniel Vasella (R), Chairman and former Chief Executive Officer of Swiss drugmaker Novartis talks to... 
Basel, Switzerland 
Novartis Chairman Vasella and CEO Jimenez chat prior their annual general meeting in Basel 
Daniel Vasella (R), Chairman and former Chief Executive Officer of Swiss drugmaker Novartis talks to his new CEO, Joe Jimenez, prior to their annual general meeting in Basel February 26, 2010. Jimenez started in his new position on February 1, 2010. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS SOCIETY) 
SWITZERLAND/
RTR2AXRK 
February 26, 2010 
Daniel Vasella, Chairman and former Chief Executive Officer of Swiss drugmaker Novartis gives an address... 
Basel, Switzerland 
Daniel Vasella, Chairman and former CEO of Swiss drugmaker Novartis gives an address at the annual general... 
Daniel Vasella, Chairman and former Chief Executive Officer of Swiss drugmaker Novartis gives an address at the annual general meeting in Basel February 26, 2010. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS SOCIETY) 
SWITZERLAND/
RTR2AXRI 
February 26, 2010 
Daniel Vasella (R), Chairman and former Chief Executive Officer of Swiss drugmaker Novartis speaks with... 
Basel, Switzerland 
Novartis Chairman Vasella and CEO Jimenez talk prior their annual general meeting in Basel 
Daniel Vasella (R), Chairman and former Chief Executive Officer of Swiss drugmaker Novartis speaks with his new CEO, Joe Jimenez prior to their annual general meeting in Basel February 26, 2010. Jimenez started in his new position on February 1, 2010. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS SOCIETY) 
Sort by 
Display 
Items per page 
Page 
of 4